Soliqs
NanoMorph
Tablet samples

Tablet samples

Introduction

Our Meltrex (melt extrusion) technology can add value to the formulation of both new molecular entities and established products. The technology has been developed by combining expertise in the fields of pharmaceuticals, polymer chemistry and analytical techniques.

This enables us to offer a collaborative partner a high level of:

  • formulation know-how to improve dissolution kinetics
  • competence in polymer and analytical research
  • proven experience from early feasibility studies through to production (including clinical trials and regulatory submission)
  • analytical services


Together with: 

The Kaletra® (Lopinavir/Ritonavir) tablet
6 Softgel Capsules
4 Meltrex® Tablets

The Meltrex tablet was developed using the SOLIQS melt-extrusion technology intended to allow patients to reduce from six soft capsules to four tablets as part of their HIV treatment regimen. In addition, the tablet will not require refrigeration, as the current soft capsule formulation does.